ValiRx plc (AIM:VAL)
London
· Delayed Price · Currency is GBP · Price in GBX 0.4500
+0.0500 (11.11%)
Jun 12, 2025, 4:35 PM GMT+1
ValiRx Market Cap
ValiRx has a market cap or net worth of 1.68 million as of June 12, 2025. Its market cap has decreased by -56.85% in one year.
Market Cap
1.68M
Enterprise Value
-261.24K
Revenue
49.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.45
Market Cap Chart
Since October 3, 2006, ValiRx's market cap has decreased from 12.83M to 1.68M, a decrease of -86.87%. That is a compound annual growth rate of -10.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.04B |
| GSK plc | 61.15B |
| Haleon | 35.79B |
| Smith & Nephew | 9.69B |
| ConvaTec Group | 5.99B |
| Hikma Pharmaceuticals | 4.66B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.30B |